Abstract
In addition to diacyl glycerophosphocholine and sphingomyelin, human plasma also contains small amounts of other glycerophospholipids, which may have special metabolic function. The structure and origin of these minor plasma lipids has not been determined. Knowledge of the detailed composition of the phospholipids of red blood cells (Myheret al., Lipids 24, 1989) permits evaluation of one of the possible sources. This study reports the detailed analyses of plasma glycerophospholipids made in parallel to those of the erythrocyte lipids obtained from the same blood using HPLC and GLC methods. The proportions of the major phospholipid classes in the plasma and erythrocytes were similar to published values, including the essential absence of diradyl glycerophosphoserine from plasma. Plasma diradyl glycerophosphocholine contained 93.0% diacyl, 3.4% alkylkacyl and 3.6% alkenylacyl, whereas the diradyl glycerophosphoethanolamine consisted of 71.8% alkenylacyl, 19.9% diacyl and 8.3% alkylacyl subclasses. The diradyl glycerophosphoinositol was 100% diacyl. The content of the minor subclasses of plasma diradyl glycerophosphocholine is similar to that of the red cells, but the ether content of the diradyl glycerophosphoethanolamine is higher in plasma than in cells. The lipid ether subclasses of plasma glycerophospholipids also contained a higher proportion of the C20, C22 and C24 alkyl and alkenyl chains than those of the cells. Furthermore, the C16 and C18-containing species in diradyl glycerophosphoethanolamine subclasses varied with the nature of the polyunsaturated acid, whereas in diradyl glycerophosphocholine subclasses the polyunsaturated acids were combined with the C16 and C18 acids in equal proportions. The significant differences in the molecular species of glycerophospholipids and sphingomyelin between plasma and red cells would appear to limit any direct transfer or equilibration of their lipid components.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- GPC:
-
glycerophosphocholine
- GPE:
-
glycerophosphoethanolamine
- GPI:
-
glycerophosphoinositol
- GPL:
-
glycerophospholipids
- GPS:
-
glycerophosphoserine
- SPH:
-
sphingomyelin
- PCo and PEo :
-
diacyl GPC and GPE
- PC′ and PE′:
-
alkylacyl GPC and GPE
- PC″ and PE″:
-
alkenylacyl GPC and GPE
References
Nelson, G.J. (1972) inBlood lipids and lipoproteins (G.J. Nelson, ed.), pp. 317–386, J. Wiley and Sons, New York, NY
Myher, J.J., Kuksis, A. and Pind, S. (1989)Lipids 24, 396–407.
Kuksis, A., Pind, S., and Myher, J.J. (1988)J. Am. Oil Chem. Soc. 65, 538–539.
Myher, J.J., Kuksis, A., Breckenridge, W.C., and Little, J.A. (1981)Can. J. Biochem. 59, 626–636.
Breckenridge, W.C., Kakis, G., and Kuksis, A. (1979)Can. J. Biochem. 57, 72–82.
Myher, J.J., and Kuksis, A. (1984)J. Biochem. Biophys. Methods 10, 13–23.
Phillips, G.B., and Dodge, J.T. (1967)J. Lipids Res. 8, 676–681.
Bowyer D.E., and King, J.P. (1977)J. Chromatogr. 143, 473–490.
Myher, J.J., Kuksis, A., Shepherd, J., Packard, C.J., Morrisett, J.D., and Gotto, A.M. (1981)Biochim. Biophys. Acta 666, 110–119.
Breckenridge, W.C., and Palmer, F.B.St.C. (1982)Biochim. Biophys. Acta 712, 707–711.
Gunstone, F.D., Ismail, I.A., and Lie Ken Jie, M (1967)Chem. Phys. Lipids 1, 376–385.
Myher, J.J., Marai, L., and Kuksis, A. (1974)J. Lipid Res. 15, 586–592.
Van Golde, L.M.G., Tomasi, V., and Van Deenen, L.L.M. (1967)Chem. Phys. Lipids 1, 282–293.
Marai, L., and Kuksis, A. (1969)J. Lipid Res. 10, 141–152.
Diagne, A., Fauvel, J., Record, M., Chap, H., and Douste-Blazy, L. (1984)Biochim. Biophys. Acta 793, 221–231.
Kuksis, A., Myher, J.J., Geher, K., Breckenridge, W.C., Jones, G.J.L., and Little, J.A. (1981)J. Chromatogr. Biomed. Applic. 224, 1–123.
Op den Kamp, J.A.F., Roelofsen, B., and Van Deenen, L.M.M. (1985)Trends Biochem. Sci. 10, 320–323.
Boegheim, J.P.J. Jr., Van Linde, M., Op den Kamp, J.A.F., and Roelofsen, B. (1983)Biochim. Biophys. Acta 735, 438–442
Kuksis, A., Myher, J.J., Breckenridge, W.C., and Little, J.A. (1979) inReport of the High Density Lipoprotein Methodology Workshop (Lippel, K., ed.), NIH Publication No. 79-1661, pp. 142–161, Bethesda, Maryland.
Dolphin, P.J. (1985)Can. J. Biochem. Cell Biol. 63, 850–869.
Child, P., Myher, J.J., Kuypers, F.A., Op den Kamp, J.A.F., Kuksis, A., and Van Deenen, L.L.M. (1985)Biochim. Biophys. Acta 812, 321–332.
Clandinin, M.T., Field, C.J., Hargraves, K., Morson, L., and Zsigmond, E. (1985)Can. J. Physiol. Pharmacol. 63, 546–556.
Shohet, S.B. (1970)J. Clin. Invest. 49, 1668–1678.
Gotto, A.M. Jr., Pownall, H.J., and Havel, R.J. (1986)Methods Enzymol. 128, 3–41.
Eisenberg, S. (1984)J. Lipid Res. 25, 1017–1058.
McLean, L.R., Demel, R.A., Socorro, L., Shinomiya, M., and Jackson, R.L. (1986)Methods Enzymol. 129, 738–783.
Ehnholm, C., and Kuusi, T. (1986)Methods Enzymol. 129, 716–738.
Albers, J.J., Chen, C.H., and Lacko, A.G. (1986)Methods Enzymol. 129, 263–283.
Pind, S., and Kuksis, A. (1986) inFat Absorption (Kuksis, A., ed.), Vol. 1, pp. 43–82, CRC Press, Boca Raton, FL.
Holub, B.J., and Kuksis, A. (1978)Adv. Lipid Res. 16, 1–125.
Author information
Authors and Affiliations
About this article
Cite this article
Myher, J.J., Kuksis, A. & Pind, S. Molecular species of glycerophospholipids and sphingomyelins of human plasma: Comparison to red blood cells. Lipids 24, 408–418 (1989). https://doi.org/10.1007/BF02535148
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02535148